Unknown PHASE3 INTERVENTIONAL 2-arm NCT02345902

Treatment of Hypoactive Delirium and Outcome Measures (THDOM)

Randomized Double-Blind Clinical Trial to Compare Haloperidol and Non-Pharmacologic Treatment Versus Non-Pharmacologic Treatment and Placebo, in Elderly Hospitalized Patients With Hypoactive Delirium

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Conditions Hypoactive Delirium

Interventions Haloperidol Placebo non-pharmacologic measures

Updated 6 times since 2017 Last updated: Apr 20, 2017 Started: Jan 31, 2016 Primary completion: Mar 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hypoactive Delirium, this trial is ongoing. The trial is conducted by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Data source: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico